Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler, Desirée Wünsch, Matthias Wirth, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 2, pp. 343-356
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents
Raafat El‐Awady, Ekram Saleh, Rifat Hamoudi, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 42, pp. 116251-116251
Open Access | Times Cited: 10
IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
Alena Gribko, Janis Stiefel, Lana Liebetanz, et al.
Diagnostics (2021) Vol. 11, Iss. 11, pp. 2040-2040
Open Access | Times Cited: 10
Spheroid culture models adequately imitate distinctive features of the renal cancer or melanoma microenvironment
Aleksandra Filipiak-Duliban, Klaudia Brodaczewska, Aleksandra Majewska, et al.
In Vitro Cellular & Developmental Biology - Animal (2022) Vol. 58, Iss. 5, pp. 349-364
Closed Access | Times Cited: 7
Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion
Alexandra L. Nguyen, Melanie Dzulko, Janine Murr, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2520-2520
Open Access | Times Cited: 8
Advances in the Correlation between Intestinal Microbiota and Breast Cancer Development
Yonglan Jiang, Xinping Chen, Shengmiao Fu
Journal of Cancer Therapy (2020) Vol. 11, Iss. 12, pp. 758-771
Open Access | Times Cited: 6
Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells
Marten A. Fischer, Al‐Hassan M. Mustafa, Kristin Hausmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway
Jiyun Choi, Jinsu Hwang, Mahesh Ramalingam, et al.
BMC Neuroscience (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity
Yingxue Yang, Shutong Chen, Qinghua Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells
Xiuyan Feng, Han Han, Yarui Guo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Prognostic significance of proteomics and multi-omics studies in renal carcinoma
Francesca Raimondo, Marina Pitto
Expert Review of Proteomics (2020) Vol. 17, Iss. 4, pp. 323-334
Open Access | Times Cited: 4
iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer
Richard Daifuku, Yu Zhang, Jingjing Wang, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access
Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities
Manasa Gangadhar Shetty, Padmini Pai, Bipasa Dey, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 1, pp. 263-278
Open Access
Recent Update on Anti-tumor Mechanisms of Valproic Acid in Glioblastoma Multiforme
Abulfazl Vatankhah, Sepehr Hoseinzadeh Moghaddam, Sadaf Afshari, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155636-155636
Closed Access
Anti-ovarian cancer migration and toxicity characteristics of a platinum(IV) pro-drug with axial HDAC inhibitor ligands in zebrafish models
Salma Begum, Scheldon D. Irvin, Carol K. Cox, et al.
Investigational New Drugs (2024)
Open Access
Epigenetics of cisplatin resistance
Anne‐Marie Baird, Steven G. Gray
Elsevier eBooks (2023), pp. 577-611
Closed Access | Times Cited: 1
Conspectus of Structurally Distinct Groups of Histone Deacetylase Inhibitors of Classical Histone Deacetylases and Sirtuins
Shabir Ahmad Ganai
(2020), pp. 159-171
Closed Access | Times Cited: 2
iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer
Richard Daifuku, Yu Zhang, Jingjing Wang, et al.
Research Square (Research Square) (2023)
Open Access
Colony Formation Assay to Test the Impact of HDACi on Leukemic Cells
Miriam Pons, Mandy Beyer
Methods in molecular biology (2022), pp. 17-25
Closed Access
Discovery of Novel Class of Histone Deacetylase Inhibitors as Anticancer Agents
Raafat El‐Awady, Ekram Salah, Rifat Hamoudi, et al.
Research Square (Research Square) (2021)
Open Access
A New Treatment Strategy for BRCA1-Related Breast Cancer
José Russo
Springer eBooks (2021), pp. 107-115
Closed Access
Previous Page - Page 2

Scroll to top